Pharmacopsychiatry

Issue 01 · January 1985

Recommend Journal

EDITORIAL
1
Netter, P.; Beckmann, H.:
Congress of the AGNP, Nuremberg 1983

PDF (62 kb)
GERONTOPSYCHIATRY
2
Heimann, H.:
Clinical Aspects of Dementia Syndrome

PDF (336 kb)
6
Häfner, H.:
Mental Disorder in Old Age - Medical and Social Risk Factors

PDF (314 kb)
12
Koeppen, D.; Netter, P.; Fischer, C.:
Individual Differences in the Effects of Clobazam on Memory Functions - Clobazam and Memory

PDF (164 kb)
15
Albus, M.; Ackenheil, M.; Engel, R. R.; Müller-Spahn, F.; Stahl, S.:
Influence of Beta-Blockers and/or Minor Tranquilizers on Autonomic Stress Reactions

PDF (130 kb)
17
Depoortere, H.:
A Comparative EEG Study of Some Benzodiazepine (BZD) and Non-BZD Sedative or Hypnotic Drugs

PDF (194 kb)
20
Hoff, P.; Dieterle, D.; Eben, E.:
The Effect of CGP 361 A, a New Beta-blocking Compound, on In-patients with Anxiety

PDF (86 kb)
22
Ruhland, M.:
Metaclazepam - a New Anxiolytic Benzodiazepine with Selective Tolerance and Crosstolerance to Other Benzodiazepines

PDF (162 kb)
24
Richter, W.; Giertz, H.:
The Effect of Supidimide and Lormetazepam on Sleep - A Controlled Clinical Study in Outpatients

PDF (108 kb)
27
Dirschedl, P.; Hasford, J.:
Drug Monitoring of Psychiatric Patients: Methodological Aspects

PDF (134 kb)
29
Strauss, A.; Scherer, J.; Friedl, F.; Rüther , E.:
The Importance of the Quantitative Description of Drug Therapy for Drug Surveillance in Psychiatry

PDF (99 kb)
31
Grohmann, R.; Scherer, S.; Schmidt, L. G.:
Adverse Drug Reactions in Psychiatric Inpatients

PDF (88 kb)
33
Oefele, K. v; Rüther, E.:
Adverse Drug Reaction Monitoring in Long-Term Psychiatric Inpatients

PDF (96 kb)
35
Haag, H.; Greil, W.; Haag, M.; Bender, W.; Rüther, E.:
Tardive Dyskinesia and Medication History

PDF (101 kb)
37
Wolf, B.; Rüther, E.:
Drug Abuse and Dependence in Psychiatric Inpatients

PDF (191 kb)
40
Schmidt, L. G.; Schüssler, G.; Linden, M.; Müller-Oerlinghausen, B.:
Impact of Adverse Drug Reactions on Treatment of Psychiatric Outpatients

PDF (123 kb)
42
Bürke, H.:
Drug Monitoring in Psychiatric Outpatient Treatment

PDF (110 kb)
44
Linden, M.; Schüssler, G.:
Low Dosage Antidepressant Treatment in Private Psychiatric Practice - A Replication Study

PDF (89 kb)
46
Balss, G.; Berzewski, H.:
The Attitude and Judgment of Psychiatrists in Private Practice in Assessing the Effect of Psychopharmaceuticals

PDF (142 kb)
48
Müller, J.; Hertrampf, R.; Müller-Oerlinghausen, B.:
Exact Costs and Clinical Impact of Routine Assessments of Psychotropic Drug Serum Levels in a Psychiatric Hospital

PDF (146 kb)
52
Möller, H. J.; Scharl, W.; von Zerssen, D.:
Can the Result of Neuroleptic Treatment be Predicted?
An Empirical Investigation on Schizophrenic Inpatients

PDF (150 kb)
54
Schöllnhammer, G.; Spechtmeyer, H.; Hesse, C.; Husser, J.; Ebeling, H.; Parish, H. M.:
Plasma Levels and Pharmacokinetics of Benperidol in Dog and Man

PDF (84 kb)
56
Schmidt, W. J.:
How Neuroleptics Control Fixed Action Patterns

PDF (96 kb)
58
Schmauss, M.; Lange, E.; Nedopil, N.; Rüther, E.; Weiss-Brummer, J.:
Effect of the Neuroleptic EMD 30-533 on Schizophrenic Symptoms: An Open Study

PDF (165 kb)
61
Auberger, S.; Greil, W.; Rüther, E.:
Tiapride in the Treatment of Tardive Dyskinesia
A Double-blind Study

PDF (101 kb)
63
Nedopil, N.; Eben, E.; Klein, H.; Krüger, R.; Rüther, E.; Schmauss, M.:
High-dosage Neuroleptic Therapy for Acute Schizophrenic Patients - Two Double-blind Studies with Benperidol

PDF (210 kb)
67
Albus, M.; Ackenheil, M.; Müller-Spahn, F.; Naber, D.; Welter, D.:
Do Norepinephrine Serum Levels Predict the Effects of Neuroleptic Withdrawal on Psychopathology?

PDF (145 kb)
69
Eben, E.; Rüther, E.:
Animal Trial Prediction and Clinical Effect of New Chemical Substances to be Used as Antipsychotic Agents

PDF (151 kb)
71
Bürki, H. R.; Alder, J.; Eichenberger, E.:
Effect of Fluperlapine on Dopaminergic Mechanisms in Rat Brain

PDF (122 kb)
73
Woggon, B.; Heinrich, K.; Küfferle, B.; Müller-Oerlinghausen, B.; Pöldinger, W.; Rüther, E.; Schied, H. W.:
Fluperlapine - a Potential Successor to Clozapine

PDF (105 kb)
75
Arendt, G.; Heinrich, K.; Tegeler, J.; Wöller, W.; Quadbeck, H.; Klieser, E.; Lange, H.; Bremberger, R.:
Clinical Side-Effects under Fluperlapine Therapy

PDF (135 kb)
78
Tegeler, J.:
A Comparative Trial of CIS(Z)-clopenthixol-decanoate and Fluphenazine-decanoate

PDF (113 kb)
83
Ott, G.; Ott, C.:
Study on the Effectiveness of Trazodone in the Treatment of Endogenous Depression. Pharmacokinetic and Psychopathometric Investigations

PDF (140 kb)
86
Schmauss, M.; Laakmann, G.; Dieterle, D.; Schmitz, R.; Wittmann, M.:
Clinical Investigation on the Importance of NE-Reuptake Inhibition for Antidepressive Efficacy: Oxaprotiline versus its R-enantiomer CGP 12-103/A

PDF (146 kb)
88
Schmauss, M.; Laakmann, G.; Dieterle, D.:
Nomifensine: A Double-blind Comparison of Intravenous versus Oral Administration in Therapy - Resistant Depressed Patients

PDF (237 kb)
91
Baumann, P.; Gaillard, J.-M.; Jonzier-Perey, M.; Gerber, C.; Bouras, C.:
Hydroxylated Metabolites of Amitriptyline in Rat Brain After Repeated Administration of the Parent Drug

PDF (141 kb)
94
Kern, U.; Richter, W.:
Clinical Comparison of Etoperidone and Amitriptyline in Endogenous Depressive Patients

PDF (106 kb)
96
Kissling, W.; Möller, H. J.; Lauter, H.; Binz, Ursula; Wendt, G.:
Double-Blind Comparison of Intravenous Versus Oral Maprotiline*. Antidepressant Activity, Plasma Levels, Side-Effects

PDF (121 kb)
98
Woggon, B.; Angst, J.; Curtius, H. Ch.; Niederwieser, A.; Levine, R. A.; Borbély, A. A.; Tobler, I.:
Tetrahydrobiopterin (BH₄) in Endogenous Depression

PDF (135 kb)
100
Müller-Oerlinghausen, B.; Fähndrich, E.:
The Relationship between Pharmacokinetic Data and the Clinical Response in Patients treated with Maprotiline or Clomipramine by Intravenous Infusion

PDF (130 kb)
102
Kropf, D.; Müller-Oerlinghausen, B.:
Assessment of Visual Perception by Means of the Signal Detection Theory in Patients under Lithium Long-term Treatment*

PDF (133 kb)
104
Kropf, D.; Müller-Oerlinghausen, B.:
The Influence of Lithium Long-term Medication on Personality and Mood*

PDF (133 kb)
106
Greil, W.; Bauer, J.; Breit, J.; Haag, M.:
Single Daily Dose Schedule in Lithium Long-Term Treatment: Effects on Pharmacokinetics and on Renal and Cardiac Functions

PDF (110 kb)
108
Fähndrich, E.; Herrmann, W. M.:
The Search for Electro-Encephalographic Variables which could Predict the Efficacy of Antidepressants

PDF (132 kb)
110
Trachsler, E.; Höchli, D.; Luckner, N. v; Woggon, B.:
Dexamethasone Suppression Test before and after Partial Sleep Deprivation in Depressed Schizophrenic and Schizoaffective Patients

PDF (108 kb)
114
Maier, W.; Philipp, M.:
Improving the Assessment of Severity of Depressive States: A Reduction of the Hamilton Depression Scale

PDF (141 kb)
116
Wacker, H. R.; Battegay, R.:
What do Psychiatric Outpatients Think about Psychopharmacotherapy?

PDF (101 kb)
118
Wendt, G.; Binz, U.; Müller, A. A.:
KUSTA (Kurz-Skala Stimmung/Aktivierung): A Daily Self-rating Scale for Depressive Patients

PDF (256 kb)
123
Sittig, W.; Kleindienst, G.; Irmisch, R.:
Effects of Food Intake on CNS Activity, Psychomotor Performance and Mood States in Healthy Volunteers

PDF (198 kb)
127
Müller, A. A.; Binz, U.; Wendt, G.:
Aspects of the Interpretation of Placebo-controlled Clinical Trials

PDF (146 kb)
129
Baumann, U.; Rösler, F.:
The Effect of Different Instructions with Different Drugs (Placebos, Tranquilizers)

PDF (141 kb)
131
Classen, W.; Feingold, E.:
Use of Placebos in Medical Practice

PDF (110 kb)
133
Schwalb, H.; Schimana, W.:
Mortality in Hospitalized Psychiatric Patients
(First Results of a 10-Year Study)

PDF (52 kb)
134
Höchli, D.; Trachsler, E.; Luckner, N. v; Woggon, B.:
Partial Sleep Deprivation Therapy of Depressive Syndromes in Schizophrenic Disorders

PDF (97 kb)
138
Jänicke, U.-A.; Hefer, B.; Coper, H.:
The Variable Maze: A Procedure for Testing Cognitive and Memory Performance and their Drug or Age Induced Changes

PDF (169 kb)
141
Menge, H. G.; Brand, U.; Kley, H.-P.:
Classification of New CNS-active Compounds by a Two-lever Drug Discrimination Procedure

PDF (117 kb)
143
Kapfhammer, H.-P.; Kuss, H.-J.; Eben, E.; Rüther, E.:
L-dopa Infusion Experiments in Combination with the L-dopa-decarboxylase Inhibitors Benserazide and Carbidopa: L-dopa Metabolism and Neuroendocrinological Effects

PDF (116 kb)
145
Reuß, F.; Schley, J.; Müller-Oerlinghausen, B.:
The Relation between Serum Concentration of α₁-acid Glycoprotein and Clinical Characteristics of Patients Treated with Perazine

PDF (126 kb)
147
Fröhler, M.; Saito, Y.; Ackenheil, M.; Bak, R.; Bondy, B.; Feistenauer, E.; Hofschuster, E.; Vakis, A.; Welter, D.:
Catecholaminergic Binding Sites on Blood Cells of Healthy Volunteers with Special Respect to Circadian Rhythms

PDF (134 kb)
149
Bondy, B.; Ackenheil, M.; Bak, R.; Feistenauser, E.; Fröhler, M.:
Catecholamine - Receptors on Blood Cells of Untreated Schizophrenic Patients

PDF (145 kb)
151
Syha, K.:
Methodical Problems with α₂-Receptor-binding Studies on Membrane Fragments of Blood Platelets in Clinical Investigations

PDF (120 kb)
153
Rommelspacher, H.; Schmidt, L.:
Increased Formation of β-carbolines in Alcoholic Patients following Ingestion of Ethanol

PDF (94 kb)
156
Rickels, K.:
Clinical Pharmacology of Benzodiazepines

PDF (330 kb)
160
Sieghart, W.:
Binding of Various Benzodiazepine Receptor Ligands to Different Benzodiazepine Receptor Subtypes

PDF (215 kb)
163
Haefely, W.:
Pharmacology of Benzodiazepine Antagonists

PDF (335 kb)
167
Stephens, D. N.; Kehr, W.; Wachtel, H.; Schmiechen, R.:
The Anxiolytic Activity of β-Carboline Derivatives in Mice, and its Separation from Ataxic Properties

PDF (254 kb)
171
Emrich , H. M.; Lund, R.:
Effect of the Benzodiazepine Antagonist Ro 15-1788 on Sleep after Sleep Withdrawal

PDF (113 kb)
174
Ruhland, M.; Liepmann, H.; Muesch, H. R.:
1.2-Anellated 1.4-Benzodiazepine Derivatives - A New Class of Antipsychotics

PDF (288 kb)
BENZODIAZEPINES
10
Müller, E.:
Benzodiazepine Receptor Interactions of Arfendazam, a Novel 1,5-Benzodiazepine*

PDF (126 kb)
DRUG SURVEILLANCE IN PSYCHIATRY
26
Helmchen, H.; Rüther, E.:
Introduction

PDF (32 kb)
NEUROLEPTIC DRUGS
50
Möller, H. J.; Follmann, U.; Scharl, W.; von Zerssen, D.:
Background Variables of Depressive States upon Discharge of Schizophrenic Inpatients Treated with Neuroleptics

PDF (181 kb)
ANTIDEPRESSANT DRUGS AND LITHIUM
80
Ott, C.; Ott, G.:
Clinical Study of Trazodone in the Treatment of Patients with Endogenous Depression. Monitoring by Means of Psychopathometric Tests

PDF (154 kb)
PSYCHOLOGICAL ASSESSMENT AND NON-DRUG FACTORS IN PHARMACOTHERAPY
112
Philipp, M.; Maier, W.:
Operational Diagnosis of Endogenous Depression. I. Comparison with Clinical Diagnosis

PDF (136 kb)
PHARMACOLOGY - BIOCHEMISTRY
136
Jänicke, B.; Wrobel, D.; Schulze, G.:
The Effects of Various Drugs on the Motor Performance Capacity of Old Rats

PDF (146 kb)
BENZODIAZEPINES: AGONISTS AND ANTAGONISTS
155
Hippius, H.; Emrich, H. M.:
Introduction

PDF (56 kb)

Archive
Free Sample Issue

Journal

About
Editorial Board
German National License
Imprint
Bluesky
Linkedin

Authors

Information for Authors
Submit a Manuscript

Subscription

Subscription Information & Contacts
Institutional Licencing

AGNP

Information for Authors
Submit a Manuscript

Collections

Information for Authors
Submit a Manuscript

Journals
Book Series
Login
Help
Portal
Return to Classic Website

German English

Thieme E-Books & E-Journals is a service of Georg Thieme Verlag and Thieme Medical Publishers, Inc.
© Georg Thieme Verlag KG

Imprint | Privacy policy statement

Your Current IP Address: 216.73.216.188